Other
Segment Reporting, Other Segment Item, Amount
Analysis
StatementIncome Statement
SectionOther
Metric ID:
other_segment_reporting_other_item_amountBusiness Segments
| Segment | Q2 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| North American Pharmaceutical | — | — | $85.63B | $87.27B | $83.25B | $83.25B | $83.25B | $83.25B |
| Oncology & Multispecialty | — | — | $11.71B | $12.71B | $11.82B | $11.82B | $11.82B | $11.82B |
| Medical-Surgical Solutions | — | — | — | — | $2.64B | $2.64B | $2.64B | $2.64B |
| Prescription Technology Solutions | — | — | — | — | $1.19B | $1.19B | $1.19B | $1.19B |
| International | $3.6B | $3.65B | — | — | — | — | — | — |
| U.S. Pharmaceutical | $70.93B | $89.23B | — | — | — | — | — | — |
| Total | — | — | — | — | — | — | — | — |
International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
